Creatine and covid relief

The short version: creatine shows plausible benefit for long-COVID recovery, but the evidence for acute COVID is absent.

Two small trials tested creatine in people already suffering long-COVID, not in acute infection. One gave 4 grams daily for six months to 12 adults with post-viral fatigue after COVID and found improvements in fatigue, exercise tolerance, and symptoms like breathing difficulty and body aches by six months [2]. Another gave creatine plus glucose for eight weeks and reported reduced long-COVID clinical features [1]. Both are tiny, and neither was funded by a manufacturer trying to sell creatine, which is a cheap unpatented supplement. That is actually a point in their favor: no profit motive to exaggerate.

The mechanistic case is real. Creatine supports mitochondrial energy production, and long-COVID is increasingly understood as a mitochondrial and vascular disorder. The same 2025 review that reported the 12-person trial also found that long-COVID patients had measurably lower creatine levels in muscle and brain tissue, and that severity of muscle pain tracked with how low the creatine was [2]. That is a coherent story: a deficiency, a plausible replacement, and a signal of improvement.

But the question was about COVID relief, not long-COVID relief. For acute COVID, there are no trials in the evidence here. No data on whether starting creatine during infection reduces severity, shortens illness, or prevents hospitalization. The two long-COVID studies started supplementation months after the acute phase. That is a different question entirely.

Creatine is generally safe at standard doses, so the risk of trying it is low. But the evidence for acute COVID relief simply does not exist in these records. The burden of proof has not been met.

My call: creatine may help long-COVID recovery based on two small trials, but there is no evidence it does anything for acute COVID. Confidence: low for acute COVID, moderate for long-COVID fatigue.